On October 18, 2018, the Board of Directors of Arbutus Biopharma Corporation appointed James Meyers and Myrtle Potter to each serve as a director for a term expiring at the company's 2019 Annual Meeting of Shareholders and until his or her successor is duly elected and qualified, except in the case of his or her earlier death, retirement or resignation. In addition, the company announced that Mr. Herbert Conrad and Dr. William Symonds resigned from the Board on October 18, 2018. The Board also appointed Mr. Meyers to be a member of the Audit Committee, Chairman of the Executive Compensation and Human Resources Committee and a member of the Corporate Governance and Nominating Committee of the Board and Ms. Potter to be a member of the Executive Compensation and Human Resources Committee of the Board. Mr. Conrad's and Dr. Symonds' decisions to resign did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practices.